Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
about
Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal CancerTowards the introduction of the 'Immunoscore' in the classification of malignant tumoursNatural Variation in Fish Transcriptomes: Comparative Analysis of the Fathead Minnow (Pimephales promelas) and Zebrafish (Danio rerio)Integrating Colon Cancer Microarray Data: Associating Locus-Specific Methylation Groups to Gene Expression-Based Classifications.Expression of the microtubule-associated protein MAP9/ASAP and its partners AURKA and PLK1 in colorectal and breast cancers.Integrated multidimensional analysis is required for accurate prognostic biomarkers in colorectal cancer.Prognostic cancer gene signatures share common regulatory motifsA 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer.Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.Network-based biomarkers enhance classical approaches to prognostic gene expression signatures.Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs.Altered pathways and colorectal cancer prognosisImproved survival among colon cancer patients with increased differentially expressed pathways.Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers.Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.Expression and clinical significance of cytochrome c oxidase subunit IV in colorectal cancer patients.Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancerMutanome and expression of immune response genes in microsatellite stable colon cancerNCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.Personalized treatment for patients with colorectal cancer: role of biomarkers.Divergent immune responses to Mycobacterium avium subsp. paratuberculosis infection correlate with kinome responses at the site of intestinal infection.A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.Impact of MLH1 expression on tumor evolution after curative surgical tumor resection in a murine orthotopic xenograft model for human MSI colon cancer.Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification.Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer.Gene expression in colon cancer: A focus on tumor site and molecular phenotype.Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevancemRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.Differentiation of high-risk stage I and II colon tumors based on evaluation of CAV1 gene expression.High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.Establishment of a 12-gene expression signature to predict colon cancer prognosis.Are Gene Signatures Ready for Use in the Selection of Patients for Adjuvant Treatment?Unsupervised analyses reveal molecular subtypes associated to prognosis and response to therapy in colorectal cancerComparison of Pre- and Post-translational Expressions of and Genes in Colorectal Adenoma-Carcinoma Tissues
P2860
Q26752457-835B6206-7767-451B-A7C9-A5CD13FA39D3Q27026489-51C3DEE6-C340-4AD9-AFB9-1F562C60B576Q28542640-2E7D6AA4-C9B4-4481-A220-23E43B547B00Q31127007-D0036AC4-3DC4-4479-A6F3-3923D292D0E7Q33616077-383A477B-BD1F-4871-9166-D5887CF657DEQ33838394-C1FFF165-C9FA-4CDD-B8A7-25DBD31E9437Q33881338-6056E48F-F11E-4215-A8FB-C02E19C5BAD5Q34227755-1F8BA5BC-FE7D-4F3E-A730-B07F342DDC25Q34494956-D88FAE61-457E-4D95-885E-9650EF65069FQ34914017-612CDED6-EEF6-4FD1-A62A-B737393585D3Q35210574-9195770C-3411-4BB8-9B9E-45D5E80C0A64Q35313181-2B2A4641-E1C2-4E78-B6A4-73BDEB9B75A5Q35321686-5E6317E6-7727-4004-A588-E8612BBCE7CFQ35671355-70FD8E8C-582F-4EB3-B2FF-F61C0168D62AQ35833089-E823050E-682A-4560-A9DD-BB802957C35CQ36049170-1DCACBFB-71B8-4FC6-AA40-5AA078A7E73DQ36582356-DF30E759-BE8A-4AB1-97AF-6849BC7CD02BQ36939031-1176F48E-5E03-432E-B29A-C79174F8C550Q36985602-CEE59886-35B3-49F9-B174-317929AB26DCQ37109573-33E97E04-A4ED-465C-8C0C-E0671D16F361Q37590339-E3F07AF4-8C1B-4C1D-B18F-6FCFD9A71EC5Q38390834-C6F54295-98AC-450E-92BE-9D7AA2B3605FQ38489765-DED83092-5B09-46E7-8268-C9AE17705092Q38647048-CED76544-B456-469E-B90A-10CF0180D8B5Q38703244-9570FFB0-B6D3-4F8B-9238-C070A2BB7EA8Q38754724-0CA2CACC-6BCF-483E-99FB-E5D7D5FA4906Q39682144-8C9D2D5C-6140-4B85-A1F7-BA4784A061F3Q40386896-04FEDD1B-76BD-43ED-A64B-40BE4B7837DAQ40740697-7C8EE4D7-2B42-4D8B-975D-60913B827458Q41135377-AF8492A3-8D17-4640-8352-3EEC76C2A759Q41136311-6FA42445-654A-46C8-87E7-0B8C503EE11EQ41505852-FD8AF1BB-0BE3-4327-9EF8-AA3006795703Q42366278-F1ACD131-E26B-47EF-AE17-757012FCF0A9Q47144679-E34C04C5-36A2-4B7F-8BFC-571774E7E410Q50098505-9026DBE7-C85E-4C02-85A8-2D65AADF72E9Q54237552-6A01CCE1-CDE9-4BC4-99FC-7E9C0FE17429Q55221256-75125CE5-9A77-434A-B358-01655541DFC3Q58053523-743B8240-1BE5-4CD0-9F0A-2E3C574B579FQ58053541-2B61185F-5550-4B56-AEB2-74222ED738E9Q58580737-E349F088-A562-40F6-87DB-901BCB73BFFE
P2860
Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical value of prognosis ge ...... l cancer: a systematic review.
@ast
Clinical value of prognosis ge ...... l cancer: a systematic review.
@en
Clinical value of prognosis ge ...... l cancer: a systematic review.
@nl
type
label
Clinical value of prognosis ge ...... l cancer: a systematic review.
@ast
Clinical value of prognosis ge ...... l cancer: a systematic review.
@en
Clinical value of prognosis ge ...... l cancer: a systematic review.
@nl
prefLabel
Clinical value of prognosis ge ...... l cancer: a systematic review.
@ast
Clinical value of prognosis ge ...... l cancer: a systematic review.
@en
Clinical value of prognosis ge ...... l cancer: a systematic review.
@nl
P2093
P2860
P50
P1433
P1476
Clinical value of prognosis ge ...... al cancer: a systematic review
@en
P2093
Antonio Soriano
Sebastiano Biondo
Xavier Sanjuan
P2860
P304
P356
10.1371/JOURNAL.PONE.0048877
P407
P50
P5008
P577
2012-11-07T00:00:00Z